Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2020-04-03 | 2020-05-08 | 110749 |
TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2020-04-03 | 2020-04-09 | 110752 |
TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2020-04-03 | 2020-05-29 | 110755 |
PEMETREXED DISODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Resolved | 2020-04-03 | 2020-04-23 | 110758 |
TEVA-PERINDOPRIL | 4MG | TABLET | Resolved | 2020-04-03 | 2020-05-08 | 110761 |
TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2020-04-03 | 2020-09-03 | 110764 |
TEVA-PREGABALIN | 225MG | CAPSULE | Resolved | 2020-04-03 | 2020-05-08 | 110767 |
TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2020-04-03 | 2020-05-21 | 110770 |
TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2020-04-03 | 2020-05-21 | 110773 |
TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2020-04-03 | 2020-04-09 | 110776 |
TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-04-03 | 2020-04-23 | 110779 |
TEVA-SILDENAFIL | 100MG | TABLET | Resolved | 2020-04-03 | 2020-04-09 | 110782 |
TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2020-04-03 | 2020-06-04 | 110785 |
TEVA-TELMISARTAN HCTZ | 80.0MG 25.0MG | TABLET | Resolved | 2020-04-03 | 2020-05-14 | 110788 |
TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Resolved | 2020-04-03 | 2020-05-01 | 110791 |
TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Resolved | 2020-04-03 | 2020-05-14 | 110794 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-03 | 2020-05-08 | 110797 |
TEVA-METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-06-04 | 110800 |
TEVA-METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-05-14 | 110803 |
TEVA-METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-04-23 | 110806 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65026 |
TEVA-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65030 |
TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT ZOPICLONE | 5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65191 |
ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65213 |
ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65218 |
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |
ACT VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65298 |
ACT VENLAFAXINE XR | 150.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65305 |
ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81298 |